These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36581444)

  • 1. Haemodynamic and prognostic associations of liver fibrosis scores in Fontan-associated liver disease.
    Martin de Miguel I; Kamath PS; Egbe AC; Jain CC; Cetta F; Connolly HM; Miranda WR
    Heart; 2023 Mar; 109(8):619-625. PubMed ID: 36581444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of fibrosis and portal hypertension in Fontan-associated liver disease in children and adults.
    Jarasvaraparn C; Thoe J; Rodenbarger A; Masuoka H; Payne RM; Markham LW; Molleston JP
    Dig Liver Dis; 2024 Aug; 56(8):1335-1342. PubMed ID: 38220486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Fibrosis Scores Are Associated With Resting and Exercise Fontan and Pulmonary Artery Wedge Pressures: Insights Into FALD.
    Miranda WR; Kamath PS; Jain CC; Connolly HC; Egbe AC
    Can J Cardiol; 2023 Oct; 39(10):1349-1357. PubMed ID: 37150355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive biomarkers of Fontan-associated liver disease.
    Emamaullee J; Khan S; Weaver C; Goldbeck C; Yanni G; Kohli R; Genyk Y; Zhou S; Shillingford N; Sullivan PM; Takao C; Detterich J; Kantor PF; Cleveland JD; Herrington C; Ram Kumar S; Starnes V; Badran S; Patel ND
    JHEP Rep; 2021 Dec; 3(6):100362. PubMed ID: 34693238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associated Factors of Liver Disease After Fontan Operation in Relation to Ultrasound Liver Elastography.
    Sethasathien S; Silvilairat S; Sittiwangkul R; Makonkawkeyoon K; Pongprot Y
    Pediatr Cardiol; 2020 Dec; 41(8):1639-1644. PubMed ID: 32740670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Fontan liver disease: Correlation of transjugular liver biopsy with magnetic resonance and hemodynamics.
    Silva-Sepulveda JA; Fonseca Y; Vodkin I; Vaughn G; Newbury R; Vavinskaya V; Dwek J; Perry JC; Reshamwala P; Baehling C; Lyon J; Davis C; Lee JW; El-Sabrout H; Shahbah D; Alshawabkeh L; Moore JW; El-Said H
    Congenit Heart Dis; 2019 Jul; 14(4):600-608. PubMed ID: 31038848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.
    Wu FM; Opotowsky AR; Raza R; Harney S; Ukomadu C; Landzberg MJ; Valente AM; Breitbart RE; Singh MN; Gauvreau K; Jonas MM
    Congenit Heart Dis; 2014; 9(5):438-47. PubMed ID: 24418160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of liver fibrosis by transient elastography and multi-parameters model in young children with chronic hepatitis B virus infection.
    Luo H; Peng S; Ouyang W; Tan Y; Jiang T; Tang L; Li S; Qiu J; Zhou C
    BMC Infect Dis; 2022 Feb; 22(1):160. PubMed ID: 35180839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
    Schleiger A; Salzmann M; Kramer P; Danne F; Schubert S; Bassir C; Müller T; Müller HP; Berger F; Ovroutski S
    Pediatr Cardiol; 2020 Apr; 41(4):736-746. PubMed ID: 32006084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of native liver fibrosis using ultrasound elastography and serological fibrosis indices in children with biliary atresia after the Kasai procedure.
    Hwang J; Yoon HM; Kim KM; Oh SH; Namgoong JM; Kim DY; Cho YA
    Acta Radiol; 2021 Aug; 62(8):1088-1096. PubMed ID: 32811156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A composite noninvasive index correlates with liver fibrosis scores in post-Fontan patients: Preliminary findings.
    Evans WN; Acherman RJ; Ciccolo ML; Carrillo SA; Galindo A; Rothman A; Mayman GA; Adams EA; Reardon LC; Winn BJ; Yumiaco NS; Shimuizu L; Inanaga Y; Deleon RJ; Restrepo H
    Congenit Heart Dis; 2018 Jan; 13(1):38-45. PubMed ID: 29194972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
    Kim WR; Berg T; Asselah T; Flisiak R; Fung S; Gordon SC; Janssen HL; Lampertico P; Lau D; Bornstein JD; Schall RE; Dinh P; Yee LJ; Martins EB; Lim SG; Loomba R; Petersen J; Buti M; Marcellin P
    J Hepatol; 2016 Apr; 64(4):773-80. PubMed ID: 26626497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
    Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
    J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive ultrasound technique for assessment of liver fibrosis and cardiac function in Fontan-associated liver disease: diagnosis based on elastography and hepatic vein waveform type.
    Koizumi Y; Hirooka M; Tanaka T; Watanabe T; Yoshida O; Tokumoto Y; Higaki T; Eguchi M; Abe M; Hiasa Y
    J Med Ultrason (2001); 2021 Apr; 48(2):235-244. PubMed ID: 33417157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection.
    Zhu X; Wang LC; Chen EQ; Chen XB; Chen LY; Liu L; Lei XZ; Liu C; Tang H
    Dig Dis Sci; 2011 Sep; 56(9):2742-9. PubMed ID: 21399926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
    Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C.
    Ragazzo TG; Paranagua-Vezozzo D; Lima FR; de Campos Mazo DF; Pessoa MG; Oliveira CP; Alves VAF; Carrilho FJ
    Clinics (Sao Paulo); 2017 Oct; 72(9):516-525. PubMed ID: 29069254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early development of hepatic fibrosis after Fontan procedure: A non-invasive study of a subclinical liver disease.
    An HS; Choi YH; Song MK; Lee SY; Kim GB; Bae EJ
    Int J Cardiol; 2020 Dec; 320():64-69. PubMed ID: 32800914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.